AbCellera Biologics Inc
ABCL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.75B
Close$
$-3.98
134.6% downside
Current Fair Value
134.6% downsideOvervalued by 134.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.75 Billion |
|---|---|
| Enterprise Value | $3.76 Billion |
| Earnings per Share | $-0.49 |
| Beta | 1.19 |
| Outstanding Shares | 318,053,142 |
Return
| Return on Equity | -13.96% |
|---|---|
| Return on Assets | -9.89% |
| Return on Invested Capital | -12.51% |
Valuation & Multiples
| P/E Ratio | -23.94 |
|---|---|
| PEG | 83.57 |
| Price to Sales | - |
| Price to Book Ratio | 3.83 |
| Enterprise Value to Revenue | 55.38 |
| Enterprise Value to EBIT | -21.02 |
| Enterprise Value to Net Income | -26 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 9, 2026
EPS
-$0.13
Est. -$0.17Revenue
$10.64 M
Est. $8.42 MNext Earnings Call
Expected Date
February 23, 2027
EPS Estimate
-$0.18
Consensus analyst estimateRevenue Estimate
$7.28 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 7.94, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.
| Put/Call Ratio | 7.9353▲ 734.83% |
|---|---|
| Total Calls | 47,900▼ 98.82% |
| Total Puts | 380,100▼ 84.08% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.73%▼ 37.27% |
|---|---|
| Total Invested | $32.55M▼ 96.42% |
| Investors Holding | 39▼ 129.00% |